On Novemeber 11,2008, Johnson and Johnson bought OMRIX for $438 M in cash when they got their FDA fibrin patch approval in May 2008.
IPO fund raising for 2008 has gotten cut in half and withdrawn in this bad financial market.
According to my research ,CTGI is missing a big market in Japan where there is a highly emotive feeling against blood transfusions during surgery.
A joint venture with a Japanese company would do wonders for the price of our stock.
Only thing is I do not know whether LTC has patents filed and approved for Japan and whether FDA or EU aaprovals would cover Japan or whether it would require some other filing.
Does anybody know if we have filed Japanese patents or FDa filings there?
Regards,
bbhuey
P.S. There is an old farm saying in winter when you see barren land you don't know what can be planted unless you have the patience to wait for the harvest.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.